Ethos Treatment Management

by Varian, a Siemens Healthineers company  · Based in United States → — AI-driven adaptive radiotherapy solution designed for personalized, real-time cancer treatment and improved patient outcomes.
Nuclear Medicine Oncology Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

The Ethos Adaptive Radiotherapy System is an innovative, AI-driven solution developed by Varian, a Siemens Healthineers company, to revolutionize cancer care. It enables personalized, real-time adaptive radiotherapy, allowing clinicians to adjust treatment plans daily based on changes in the patient’s anatomy and tumor characteristics. This approach aims to precisely target tumors while minimizing dose to surrounding healthy tissues, potentially improving overall outcomes. The system integrates advanced imaging capabilities, such as HyperSight, for rapid and high-quality image acquisition, and leverages AI for automated contouring and optimized treatment planning and delivery. Ethos is designed to streamline workflows, making adaptive therapy more accessible and efficient for clinics and patients.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-driven adaptive radiotherapy
  • Real-time treatment plan adaptation
  • HyperSight imaging solution for rapid, high-quality imaging
  • AI-powered planning and contouring (automates over 70 anatomical structures)
  • Streamlined workflow for faster treatment delivery (e.g., 15-minute sessions)
  • Multimodality image support (MR, PET, CT, CBCT)
  • Online or offline adaptation options
  • Integration with ARIA CORE oncology management solution
  • Direct dose calculation on CBCT images
  • Personalized treatment plans

Use Cases

  • Prostate cancer treatment
  • Kidney cancer treatment
  • Pancreatic cancer treatment
  • Rectal cancer treatment
  • Gynecologic malignancies (cervical and uterine cancers)
  • Treatment of tumors in head & neck, thorax, abdomen, pelvis, and bowel regions

What Physicians Need to Know

Key Capabilities
Ethos Treatment Management offers AI-driven adaptive radiotherapy, enabling real-time treatment adaptation based on daily anatomical changes. It features AI planning and segmentation, automatically contouring over 70 anatomical structures across various body regions (head & neck, thorax, abdomen, pelvis, bowel). The system supports multiple treatment techniques including IGRT, IMRT, VMAT, and SBRT, and integrates HyperSight imaging for direct dose calculation and multi-modality image utilization (MR, PET, CT, CBCT).
Clinical Utility
The tool provides personalized cancer care by adjusting treatment plans daily to optimize target coverage and reduce dose to healthy tissues, potentially improving patient outcomes. It is particularly beneficial for cancers where tumor or organ positions may shift, such as prostate, lung, bladder, gynecologic, head & neck, abdomen, pelvis, and bone metastases. Ethos aims to deliver adaptive treatments efficiently, with sessions potentially as short as 15-20 minutes.
Integration Options
Ethos facilitates seamless data sharing and exchange with Varian's ARIA CORE oncology management solution for comprehensive patient management. It also allows for the integration of diagnostic MR, PET, and CT images during the planning and treatment phases.
Compliance Status
Ethos Treatment Management has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its functionality, including recent enhancements in Ethos 2.0. It also holds a CE mark, granted in February 2023.
Pricing Model
Specific pricing models for Ethos Treatment Management are not publicly disclosed by Varian. One study indicated an incremental cost per additional adaptive fraction of approximately $103.58 in the United States.
User Experience
Designed with a streamlined, guided workflow, Ethos aims to simplify decision-making and reduce manual effort through AI-driven planning and contouring. Providers reportedly choose the adapted treatment plan 88% of the time, indicating perceived benefit. While efficient for adaptive therapy, some users note it can be less integrated with other Varian systems like ARIA and Eclipse for non-adaptive workflows.
Support Quality
While no specific details on 'support quality' were found, Varian, as a major medical device manufacturer, typically provides comprehensive customer support for its products.
Implementation Complexity
Implementing Ethos requires a highly skilled multidisciplinary team and additional staff training for validating AI-driven contouring. There can be significant upfront time involved in developing workable 'RT intents'. However, the system is designed to reduce overall workflow complexity for adaptive radiotherapy.
Evidence Base
Moderate quality evidence from observational studies suggests that online adaptive radiotherapy with Ethos can improve short-term dosimetric outcomes, such as target coverage and organ sparing. Clinical studies and cases are referenced by Varian, and the dosimetric accuracy of the system has been verified. The AI models used for segmentation are based on static convolutional neural networks and do not continuously learn from user input.
Physician Tip

Ethos Treatment Management significantly enhances the ability to deliver personalized, adaptive radiotherapy, crucial for tumors in areas with high anatomical variability. Leverage its AI-driven contouring and planning to streamline daily workflows and ensure precise dose delivery. While highly effective for adaptive treatments, be mindful of potential workflow adjustments when integrating with existing non-adaptive Varian systems (e.g., ARIA, Eclipse) for comprehensive patient management, as some data export may be required for full dose accumulation or multi-site treatment summaries. The system's rapid adaptation capabilities can lead to shorter treatment times and potentially better patient outcomes by minimizing radiation to healthy tissue.

Ethos is designed to integrate seamlessly with Varian's ARIA CORE oncology management solution, facilitating efficient patient data capture, treatment progress updates, and administrative tasks. It also supports the use of multi-modality diagnostic images (MR, PET, CT) for enhanced planning. While core adaptive workflows are integrated within Ethos, some users have noted that its integration with other Varian systems for non-adaptive or historical data review (e.g., dose sums across different machines or prior treatments) may require specific data export processes.

Details

Category Oncology AI, Radiology & Imaging AI
Pricing Contact for pricing — Not publicly disclosed; requires direct consultation with Varian/Siemens Healthineers.
DeploymentOn-premise
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The Ethos therapy system received its initial FDA 510(k) clearance in February 2020. Subsequent 510(k) clearances have been granted for new functionalities and enhancements, including Ethos 2.0 with HyperSight imaging, in February 2023 and July 2024, expanding its capabilities for daily treatment adaptation across various body areas.
Integrations
EHR Not specified
Specialties Nuclear Medicine, Oncology, Radiology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Ethos Treatment Management

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

accessdata.fda.gov (FDA)
Indications for Use - Ethos Treatment Management, Ethos Treatment Planning, Ethos Radiotherapy System, and Halcyon
This regulatory document from the FDA outlines the indications for use for Varian's Ethos Treatment Management, Ethos Treatment Planning, Ethos Radiotherapy System, and Halcyon, stating they are used for managing, monitoring, generating, and modifying radiation therapy treatment plans and sessions. It also details the substantial equivalence argument to predicate devices.
2020-02
FDA.report
510(k) Premarket Notification - K232923 - Ethos Treatment Management 3.0 and Ethos Treatment Planning 2.1
This FDA 510(k) summary details the substantial equivalence determination for Ethos Treatment Management 3.0 and Ethos Treatment Planning 2.1, highlighting their intended use in managing and monitoring radiation therapy treatment plans and sessions. It also mentions the software's 'major' level of concern due to potential for serious injury or death in case of failure.
2024-04
Journal of Applied Clinical Medical Physics (PMC)
Commissioning a standalone adaptive radiotherapy linac in a multiu2010vendor environment
This peer-reviewed article describes the successful implementation of the Varian Ethos Treatment Management system in a multi-vendor clinical environment for both non-adaptive and online adaptive therapy. It highlights Ethos's role as both a treatment planning system and an Oncology Information System, and its reliance on an external ARIA server for patient data.
2022-01
Journal of Applied Clinical Medical Physics (PMC)
A head and neck treatment planning strategy for a CBCTu2010guided ringu2010gantry online adaptive radiotherapy system
This peer-reviewed article evaluates the capabilities of the Ethos CBCT-guided ring-gantry online adaptive radiotherapy system for head and neck treatments, focusing on developing an optimal strategy for initial plan generation and efficient online adaptation. It discusses the use of an Ethos emulator software package for planning and simulating adaptive workflows.
2023-08
Frontiers in Oncology
Daily artificial intelligence-assisted adaptive small margin radiotherapy during trimodal therapy of muscle-invasive bladder cancer
This article details the use of Varian Ethos Treatment Unit Version 1.1 and Ethos Treatment Management Version 2.1 for daily online adaptive radiotherapy in patients with muscle-invasive bladder cancer. It emphasizes the role of AI-based auto-contouring and plan optimization in the adaptive workflow.
2023-09
Cyber Security Agency of Singapore
Varian Ethos Treatment Management | Cyber Security Agency of Singapore
This regulatory entry from the Cyber Security Agency of Singapore lists Varian Ethos Treatment Management (Model No.: Ethos Treatment Management 3.0) as a registered medical device in the Radiology product category. It includes details such as the manufacturer, product name, and registration IDs.
2026-06
SFPM
Power new victories with the adaptability of Ethos - SFPM
This document highlights the adaptability of Ethos Treatment Management, emphasizing its AI treatment planning capabilities, integration with ARIA Oncology Information System, and efficiency in adaptive radiotherapy workflows. It also mentions the system's ability to unify IGRT treatments with other Varian linacs.
unknown
ResearchGate
Investigating the impact of rapidplan on ethos automated planning
This research investigates the performance of Ethos automated planning with knowledge-based guidance, specifically using Rapidplan (RP), and finds that while non-RP plans achieved comparable target coverage, the inclusion of the RP model reduced OAR doses.
2025-09

Videos

Product demos, reviews, and walkthroughs for Ethos Treatment Management.

View all on YouTube

Frequently Asked Questions

Ethos Adaptive Radiation Therapy utilizes AI to streamline and enhance the radiation therapy workflow, from initial planning to real-time treatment delivery. It uses AI for rapid treatment planning, contouring, and adjusting radiation dosage based on daily anatomical changes observed through imaging like iCBCT. This allows for personalized treatment plans that adapt to the patient's changing anatomy during the course of therapy.
Ethos Therapy has received FDA 510(k) clearance, indicating it meets the safety and effectiveness standards for medical devices. While specific data privacy measures like HIPAA compliance are inherent to healthcare technology in the US, the system is designed to capture and manage clinical treatment data securely, communicating with systems like ARIA for seamless data capture and progress updates.
While Ethos offers significant advancements, potential challenges could include the initial capital investment for the system, the need for specialized training for clinical staff, and ensuring seamless integration with existing hospital IT infrastructure. The capacity of artificial intelligence continues to evolve, suggesting ongoing development and potential for broader application in the future.
Alternatives to Ethos Adaptive Radiation Therapy would typically include other advanced radiation therapy systems that offer adaptive capabilities, though Ethos is noted for its real-time, on-couch adaptation. Conventional external beam radiation therapy, which may involve more manual adjustments and longer replanning times, is a more traditional alternative.
The search results do not provide specific pricing or reimbursement details for the Ethos Adaptive Radiation Therapy system. Generally, high-tech medical devices like Ethos involve significant capital expenditure for healthcare facilities, with reimbursement typically falling under existing radiation oncology billing codes, though specific adaptive therapy procedures may have distinct coding considerations.
Ethos therapy improves patient outcomes by enabling real-time adjustments to treatment plans based on daily anatomical changes, ensuring radiation is precisely targeted to the tumor while sparing healthy tissue. This precision can reduce side effects and potentially improve overall outcomes. It also enhances efficiency by generating and adapting treatment plans within minutes, eliminating lengthy delays for manual recalculations.
While Ethos uses AI for rapid planning and adaptation, physician oversight remains crucial. The physician defines clinical intent and objectives, and the initial treatment plan is generated based on these. Treatment plans, including adaptive ones, are reviewed and checked by a radiation technologist and a physician before delivery, ensuring clinical validation of AI-driven recommendations.

Related Tools

Surgical Reality Viewer
Surgical Reality
Oncology AI
Surgical Reality offers CE- and FDA-certified AI-powered 3D medical imaging and surgical planning software that transforms CT scans into patient-specific 3D models for thoracic surgery, enhancing precision in complex lung procedures.
Cancer Copilot
Color Health
Oncology AI
Color Health's Cancer Copilot, built with OpenAI, helps oncologists and clinicians identify and order workup needs for recently diagnosed patients, aiming to speed up time to cancer treatment. This AI tool is designed to expand cancer expertise, speed decisions, and improve care, reducing a two-hour clinical task to 10 minutes with over 95% validated accuracy.
Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
Synapse Lung Nodule AI
Fujifilm Corporation
Oncology AI
Fujifilm's Synapse Lung Nodule AI is an AI software algorithm for detecting pulmonary nodules on CT imaging, aiming to support early detection and treatment of lung cancer.
On request
RadOncAI
Informai (for RadOncAI product) / Global Network for AI in Radiation Oncology (for RadoncAI.net)
Oncology AI
RadOncAI is an AI solution by Informai designed to optimize and enhance radiation oncology workflows, improving efficiency and accuracy in treatment planning and delivery.
FAITH project (Fatigue Therapy – AI-supported Diagnosis and Therapy of Tumour-associated Fatigue Syndrome)
Fimo Health GmbH (Consortium Leader)
Mental & Behavioral Health AI
The FAITH project is developing an AI-based solution for the diagnosis and therapy of tumor-associated fatigue syndrome in cancer patients. It uses wearable sensors, a smartphone app, and artificial intelligence to provide individualized therapy recommendations and monitor mental health.

See all Oncology AI tools →

Suggest an Edit → | Last Verified: 2026-04-21 | First Added: 2026-04-21
AI Tool Finder
AI-powered search. Results may not be comprehensive.